David Olivares

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Ulcerative Colitis

Patient Reported

Top Venues

Alimentary pharmacology & therapeutics

Rheumatology international

Current medical research and opinion

Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Taxonera, David Olivares, Olga N López-García, Cristina Alba
Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis. Alimentary pharmacology & therapeutics (2023)
Carlos Taxonera, David Olivares, Olga N López-García, Cristina Alba
Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis. Alimentary pharmacology & therapeutics 57 (6) (2023)
Carlos Taxonera, David Olivares, Olga N López-García, Cristina Alba
Meta-analysis: Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis. Alimentary pharmacology & therapeutics 57 (6) (2023)
Carlos Taxonera, David Olivares, Cristina Alba
Recommendations for the detection of latent tuberculosis infection in patients with immune-mediated inflammatory diseases candidates for anti-TNF therapy may not be applicable in all settings. Rheumatology international (2021)
David Olivares, Cristina Alba, Irene Pérez Enciso, Valentín Roales, Enrique Rey, Carlos Taxonera
Differences in the need for adalimumab dose optimization between Crohn's disease and ulcerative colitis. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 111 (11) (2020)
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors. Authors' reply. Alimentary pharmacology & therapeutics 52 (3) (2020)
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey
2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Alimentary pharmacology & therapeutics 52 (2) (2020)
Carlos Taxonera, Marisa Iborra, Marta Maia Bosca-Watts, Saioa Rubio, Óscar Nantes, Rebeca Higuera, Federico Bertoletti, Pilar Martínez-Montiel, Mónica Sierra-Ausin, Noemí Manceñido, José Lázaro Pérez-Calle, Alicia Algaba, David Olivares, Cristina Alba
Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis. Current medical research and opinion 35 (7) (2019)